Rare Alleles of c-Ha-ras in Breast Cancer Patients
Author Information
Author(s): G.R.M. White, J. Heighway, G.T. Williams, D. Scott
Primary Institution: Paterson Institute for Cancer Research
Hypothesis
The high incidence of rare alleles in breast cancer patients may be due to technical difficulties.
Conclusion
The study found no significant difference in rare allele frequencies between breast cancer patients and controls.
Supporting Evidence
- The study found no significant difference in rare allele frequencies between breast cancer patients and controls.
- Previous studies suggested a significant increase in rare alleles in other cancer types, but not in breast cancer.
Takeaway
The researchers looked at a specific gene in breast cancer patients and found that it didn't seem to be linked to the disease.
Methodology
The study analyzed c-Ha-ras RFLPs in blood samples from breast cancer patients and compared them to a control group.
Potential Biases
Potential bias due to differences in sample quality between tumor and blood DNA.
Limitations
The study relied on blood samples, and tumor DNA may have been more impure or degraded.
Participant Demographics
80 breast cancer patients compared to 101 controls.
Statistical Information
P-Value
0.706
Statistical Significance
p=0.706
Want to read the original?
Access the complete publication on the publisher's website